Chief Financial Officer of Adagio Medical, Inc.
John was previously Chief Financial Officer of Santa Cruz Nutritionals and before that, Acutus Medical. He has more than 20 years of experience leading financing and accounting in the health and medical device spaces.
Senior Advisor at Boston Consulting Group
Ruth brings more than 15 years of leadership experience in executive and human resource management for a variety of industries and Fortune 500 companies. Ms. Fattori serves on the board of directors of Quantum-Si, which created the world’s first next-generation protein sequencing platform.
Chairman of the Board of Hyperfine
Scott has played a key role in more than 20 medtech start-up, growth, and public companies with market valuations totaling over $20 billion, that cumulatively have delivered therapeutics and diagnostics to more than 20 million patients. Mr. Huennekens has been named Ernst & Young Entrepreneur of the Year in 2010 and was recognized by Goldman Sachs in 2016, 2017, and 2018 as one of their 100 Most Intriguing Entrepreneurs.
Founder of Hyperfine
Jonathan is a serial entrepreneur with more than 20 years of experience who founded and invented massively parallel DNA sequencing, semiconductor sequencing, and ultrasound-on-a-chip (Butterfly Network). In 2016, he was awarded the National Medal of Technology and Innovation for his “pioneering inventions and commercialization of next-generation DNA sequencing technologies, making access to genomic information easier, faster, and more cost-effective for researchers around the world.”
President and CEO of Hyperfine

Maria is the President and CEO of Hyperfine. She previously served as the President and CEO of AEGEA Medical Inc., a women’s health technology company acquired by CooperSurgical in 2021. She serves as a member of the Board of Directors of ShockWave Medical, Inc., Avanos Medical, Inc., and Atrion Corporation. Ms. Sainz brings more than 20 years of experience leading large medical device companies and medtech start-ups.

CEO of Wolterman Consulting, LLC
Daniel has more than 30 years of experience in the healthcare industry, holding various leadership roles, including serving as President and CEO of Memorial Hermann Health System, the largest not-for-profit health system in the Houston region of Texas. He most recently served on the board of directors of NuVasive, (acquired by GMED on 9/1/23), previously a Nasdaq-listed company focused on developing medical devices and procedures for minimally invasive spine surgery.